G1 Therapeutics Inc
(GTHX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,300 | 94,657 | 93,301 | 144,020 | 183,083 |
| Marketable Securities | 48,080 | 50,476 | 29,744 | N/A | N/A |
| Receivables | 16,025 | 11,094 | 10,521 | 10,787 | 7,615 |
| Inventories | 15,543 | 16,179 | 13,950 | 14,014 | 7,860 |
| TOTAL | $153,965 | $179,500 | $157,465 | $177,100 | $208,336 |
| Non-Current Assets | |||||
| PPE Net | 1,857 | 1,989 | 2,126 | 2,265 | 1,898 |
| Other Non-Current Assets | 6,135 | 6,476 | 6,982 | 7,514 | 8,005 |
| TOTAL | $7,992 | $8,465 | $9,108 | $9,779 | $9,903 |
| Total Assets | $161,957 | $187,965 | $166,573 | $186,879 | $218,239 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,380 | 7,431 | 8,442 | 9,349 | 11,018 |
| Accrued Expenses | 22,767 | 25,557 | 27,251 | 26,599 | 22,577 |
| Other current liabilities | 5,038 | 2,593 | 1,432 | 1,294 | 1,371 |
| TOTAL | $33,690 | $35,588 | $37,134 | $37,252 | $34,983 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,470 | 77,015 | 76,558 | 76,102 | 75,646 |
| Deferred Revenues | 505 | 7 | 9 | 10 | 17 |
| Other Non-Current Liabilities | 5,309 | 5,615 | 5,916 | 6,200 | 6,478 |
| TOTAL | $83,279 | $83,630 | $83,474 | $83,302 | $83,124 |
| Total Liabilities | $116,969 | $119,218 | $120,608 | $120,554 | $118,107 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,661 | 51,658 | 42,912 | 42,747 | 42,706 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -759,613 | -732,018 | -698,369 | -673,097 | -633,651 |
| Other shareholders' equity | -8 | -8 | -8 | -8 | -8 |
| TOTAL | $44,988 | $68,747 | $45,965 | $66,325 | $100,132 |
| Total Liabilities And Equity | $161,957 | $187,965 | $166,573 | $186,879 | $218,239 |